Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Mazen S. Zenati"'
Autor:
Jason B. Liu, Vernissia Tam, Mazen S. Zenati, Danielle Schwartz, Areej Ali, Carissa A. Low, Lillian J. Smith, Herbert J. Zeh, Amer H. Zureikat, Melissa E. Hogg
Publikováno v:
HPB. 24:1659-1667
Robotic-assisted pancreatectomy continues to proliferate despite limited evidence supporting its benefits from the patient's perspective. We compared patient-reported outcomes (PROs) between patients undergoing robotic and open pancreatectomies.PROs,
Autor:
Amr I. Al Abbas, Ahmad B. Hamad, Mazen S. Zenati, Amer H. Zureikat, Herbert J. Zeh, Melissa E. Hogg
Publikováno v:
HPB. 24:1770-1779
Pancreatoduodenectomy (PD) remains associated with significant complication and readmission rates. Infection constitutes a significant proportion of morbidity. We aim to evaluate whether CT scans performed prior to discharge for suspected infection p
Autor:
Jurgis Alvikas, Jan O. Jansen, Adnan Hassoune, Heather M Phelos, Mazen S. Zenati, Matthew D. Neal, Insiyah Campwala, David O. Okonkwo
Publikováno v:
The Journal of Trauma and Acute Care Surgery
Supplemental digital content is available in the text.
BACKGROUND Rapid platelet function testing is frequently used to determine platelet function in patients with traumatic intracranial hemorrhage (tICH). Accuracy and clinical significance of
BACKGROUND Rapid platelet function testing is frequently used to determine platelet function in patients with traumatic intracranial hemorrhage (tICH). Accuracy and clinical significance of
Autor:
Amer H. Zureikat, Ibrahim Nassour, David L Bartlett, Annissa Desilva, Lance A. Liotta, Aatur D. Singhi, Virginia Espina, Alessandro Paniccia, Samer AlMasri, Nathan Bahary, Brian A. Boone, Herbert J. Zeh, Patricia Loughran, Michael T. Lotze, Mazen S. Zenati
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Introduction Preoperative autophagy inhibition with hydroxychloroquine (HCQ) in combination with gemcitabine in pancreatic adenocarcinoma (PDAC) has been shown to be safe and effective in inducing a serum biomarker response and increase resection rat
Autor:
Shimena R Li, Terence O'Keeffe, Mazen S. Zenati, Joshua D. Brown, Katherine M. Reitz, Matthew D. Neal, Gary Vercruysse, Bellal Joseph, Raminder Nirula, Francis X. Guyette, Brian S. Zuckerbraun, Brian J. Eastridge, Jason L. Sperry
Publikováno v:
Ann Surg
OBJECTIVE We sought to characterize the timing of administration of prehospital tranexamic acid (TXA) and associated outcome benefits. BACKGROUND TXA has been shown to be safe in the prehospital setting post-injury. METHODS We performed a secondary a
Autor:
James A. Brown, Richard L. Simmons, Amer H. Zureikat, Mazen S. Zenati, Melissa E. Hogg, Jae P. Jung, Amr I. Al Abbas, Herbert J. Zeh
Publikováno v:
HPB. 23:144-153
Background Cholangitis due to anastomotic stricture of the hepaticojejunostomy (HJ) following pancreaticoduodenectomy (PD), while uncommon, adversely affects postoperative quality-of-life. While prior studies have identified patient-related risk fact
Autor:
Rohit Das, Savreet Sarkaria, Randall E. Brand, Alessandro Paniccia, Samer AlMasri, Kenneth E. Fasanella, Melissa E. Hogg, Anil K. Dasyam, Jennifer Chennat, Asif Khalid, Kenneth K. Lee, Adam Slivka, Herbert J. Zeh, Mazen S. Zenati, Amer H. Zureikat, David L. Bartlett, Aatur D. Singhi, Kevin McGrath
Publikováno v:
Annals of Surgery. 275:e789-e795
OBJECTIVE To evaluate the significance of UDD in IPMNs. BACKGROUND The uncinate process of the pancreas has an independent ductal drainage system. International consensus guidelines of IPMNs still consider it as a branch-duct, even though it is the m
Autor:
Mazen S. Zenati, Amer H. Zureikat, Melissa E. Hogg, Amr I. Al Abbas, Herbert J. Zeh, Jae Pil Jung, Caroline J. Reiser, Ahmad Hamad
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Optimal cut-offs for CA19-9 response after neoadjuvant therapy (NT) for pancreatic adenocarcinoma (PDAC) are not well characterized. This study aims to analyze the relationship of serum CA19-9 with other markers of response and identify
Autor:
Brian A. Boone, Joal D. Beane, Mazen S. Zenati, Herbert J. Zeh, A. James Moser, Melissa E. Hogg, David L. Bartlett, Amr I. Al Abbas, Amer H. Zureikat
Publikováno v:
Ann Surg
OBJECTIVES: This study aims to present the outcomes of our decade-long experience of robotic pancreatoduodenectomy and provide insights into successful program implementation. BACKGROUND: Despite significant improvement inmortality over the past 30 y
Autor:
Caroline J. Rieser, David L. Bartlett, Asmita Chopra, Kenneth K.W. Lee, Sowmya Narayanan, Amer H. Zureikat, Alessandro Paniccia, Samer AlMasri, Tracy Daum, Mazen S. Zenati, Katelyn Smith, Nathan Bahary, Vivianne Oyefusi, Ibrahim Nassour
Publikováno v:
J Surg Oncol
BACKGROUND AND OBJECTIVES Neoadjuvant chemotherapy (NAT) for pancreatic adenocarcinoma (PDAC) is increasingly being utilized. However, a significant number of patients will experience early recurrence, possibly negating the benefit of surgery. We aim